← Back to Search

Healthbot Support for Medication Adherence

N/A

Recruiting

Led By Nadia Minian, PhD

Research Sponsored by Centre for Addiction and Mental Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

Study Summary

This trial aims to develop and evaluate a healthbot to help people stick to their varenicline regimen, by researching the challenges to adherence and how a healthbot might help.

Who is the study for?

This trial is for treatment-seeking smokers over 18 in Ontario who smoke 10+ cigarettes daily, are ready to start and stick with varenicline for 12 weeks, set a quit date soon, speak English, have a smartphone with data, and commit to follow-ups. It's not for those with varenicline contraindications or pregnant/breastfeeding women.Check my eligibility

What is being tested?

The study tests a healthbot designed to help people stick to their varenicline regimen. Participants will use the healthbot over 12 weeks while researchers measure its effectiveness on medication adherence and smoking cessation using interviews and feedback.See study design

What are the potential side effects?

While this study focuses on the healthbot's usability rather than medication side effects, participants should be aware that varenicline can cause nausea, sleep problems (insomnia), constipation, gas and/or vomiting.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability

Adoption

Appropriateness

+2 more

Secondary outcome measures

Medication Adherence

Smoking Status

Side effects data

From 2022 Phase 4 trial • 39 Patients • NCT04011280

50%

Dysgeusia

50%

Anxiety

36%

Sleep Disturbances

29%

Nausea

21%

Depression

21%

Agitation

21%

Headache

14%

Allergies

14%

Heartburn

14%

Cold

14%

Back Pain

Cellulitis

Sinusitis

Stomach Pain

Panic

Angina

Aggression

Palpitations

Rash

Confusion

Dizziness

Fatigue

Leg Spasms

Increased Blood Pressure

Malaise

Weight Gain

Gum Disease

Pharyngitis

Leg Cramps

Muscle Pain

100%

80%

60%

40%

20%

Study treatment Arm

Low Dose Varenicline

Standard Dose Varenicline

Trial Design

1Treatment groups

Experimental Treatment

Group I: Varenicline healthbotExperimental Treatment1 Intervention

While the exact healthbot features will be based on results from the rapid review, interviews and Wizard of OZ testing, the investigators know from the existing literature on medication adherence, and behaviour change interventions, that the healthbot will provide: 1) reminders for varenicline dosing and schedule; 2) information and suggestions on managing known side effects (the most frequently cited reason for varenicline non-adherence is experiencing side effects); 3) answers to questions about medication use (e.g., what to do if a dose is missed); and 4) support to increase participants' motivation to continue their quit attempts. During the next 12 weeks, participants will be reminded by the healthbot to take their varenicline at the appropriate times, and will be able to interact with the healthbot when they want.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Centre for Addiction and Mental HealthLead Sponsor

356 Previous Clinical Trials

81,418 Total Patients Enrolled

Canadian Institutes of Health Research (CIHR)OTHER_GOV

1,345 Previous Clinical Trials

26,453,474 Total Patients Enrolled

Canadian Cancer Society (CCS)OTHER

78 Previous Clinical Trials

37,705 Total Patients Enrolled

Media Library

Varenicline healthbot Clinical Trial Eligibility Overview. Trial Name: NCT05997901 — N/A

Medication Adherence Research Study Groups: Varenicline healthbot

Medication Adherence Clinical Trial 2023: Varenicline healthbot Highlights & Side Effects. Trial Name: NCT05997901 — N/A

Varenicline healthbot 2023 Treatment Timeline for Medical Study. Trial Name: NCT05997901 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being treated with this experiment?

"Affirmative. The clinicaltrials.gov website states that recruitment for this medical study, which was posted on October 12th 2022, is currently ongoing. 40 patients will be taken in at a single site."

Answered by AI

Are there still enrollments being accepted for this clinical experiment?

"This experiment is currently enrolling participants. The initial posting was on 12th October 2022 with the latest update being 10th August 2023, both according to clinicaltrials.gov."

Answered by AI